Astle Medipharma Private Limited - Company Profile

It is a chemicals private limited company based in Aligarh, Uttar Pradesh, India, established in 2013.
2013 Aligarh, Uttar Pradesh, India Struck Off
Last Updated:
Access Report
About Astle Medipharma Private Limited

Astle Medipharma Private Limited, a struck off private limited company, was established on 12 November 2013 in Aligarh, Uttar Pradesh, India. Engaging in basic chemical within the chemicals sector, it holds CIN: U24100UP2013PTC060573. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹0.30 M and a paid-up capital of ₹0.10 M.

Its leadership includes Khalid Khan Ali (Director), Naved Ahmad Khan (Managing Director), Mohsin Khan (Director). Past directors included Mohd. Jahangeer. It is based at C-3, Hamdard Nagar Tower Hamdard Nagar-B, Jamalpur, Aligarh, Uttar Pradesh, 202001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100UP2013PTC060573

  • Registration Number

    060573

  • Incorporation Date

    12 November 2013

  • Authorized Capital

    ₹0.30 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.30 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 12 Year, 5 Months
Company report

Astle Medipharma Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Astle Medipharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Astle Medipharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Khalid Khan Ali Director 25 Jul 2014 Current
Naved Ahmad Khan Managing Director 12 Nov 2013 Current
Mohsin Khan Director 12 Nov 2013 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Company Secretary - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Astle Medipharma.

Enhance accessibility to Astle Medipharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Astle Medipharma revenue growth over time
Astle Medipharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Astle Medipharma?

Unlock access to Astle Medipharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Astle Medipharma?

Unlock and access historical data on people associated with Astle Medipharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Astle Medipharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Astle Medipharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Astle Medipharma
Recent Activity within the Organization
  • Director Appointment

    Khalid Khan Ali was appointed as a Director was appointed as a Director on 25 Jul 2014 & has been associated with this company since 11 years 9 months . was recorded as a recent event.

  • Director Appointment

    Naved Ahmad Khan was appointed as a Managing Director was appointed as a Managing Director on 12 Nov 2013 & has been associated with this company since 12 years 5 months . was recorded as a recent event.

  • Director Appointment

    Progress on Mohsin Khan was appointed as a Director was appointed as a Director on 12 Nov 2013 & has been associated with this company since 12 years 5 months . was documented.

  • Company Incorporation

    The activity Astle Medipharma Private Limited was registered on 12 Nov 2013 with Roc Kanpur & aged 12 years 5 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Astle Medipharma Private Limited?

The CIN of Astle Medipharma Private Limited is U24100UP2013PTC060573.

Where is Astle Medipharma Private Limited headquartered?

Astle Medipharma Private Limited is headquartered at C-3, Hamdard Nagar Tower Hamdard Nagar-B, Jamalpur, Aligarh, Uttar Pradesh, 202001.

When was Astle Medipharma Private Limited incorporated?

Astle Medipharma Private Limited was incorporated on 12 November 2013.

Who are the current directors of Astle Medipharma Private Limited?

The current directors of Astle Medipharma Private Limited are

What is the primary industry of Astle Medipharma Private Limited?

The primary industry of Astle Medipharma Private Limited is Chemicals.

Is Astle Medipharma Private Limited a listed company?

Astle Medipharma Private Limited is unlisted.

What is the capital structure of Astle Medipharma Private Limited?

The authorized capital of Astle Medipharma Private Limited is ₹0.30 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available